• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

去卵巢小鼠的骨密度降低,经后续重复间歇性给予(R)-氯胺酮后得到改善,但(S)-氯胺酮无效。

Decreased bone mineral density in ovariectomized mice is ameliorated after subsequent repeated intermittent administration of (R)-ketamine, but not (S)-ketamine.

机构信息

Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan.

出版信息

Neuropsychopharmacol Rep. 2020 Dec;40(4):401-406. doi: 10.1002/npr2.12132. Epub 2020 Aug 19.

DOI:10.1002/npr2.12132
PMID:32812706
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7722686/
Abstract

AIM

Depression is a common symptom in people with osteoporosis. (R)-ketamine produced greater potency and longer-lasting antidepressant-like actions than (S)-ketamine in rodents. Here, we examined the effects of two ketamine enantiomers on the reduced bone mineral density (BMD) in the ovariectomized (OVX) mice which is an animal model of postmenopausal osteoporosis.

METHODS

Female ddY mice were OVX or sham-operated. Subsequently, saline (10 mL/kg/d, twice weekly), (R)-ketamine (10 mg/kg/d, twice weekly), or (S)-ketamine (10 mg/kg/d, twice weekly) was administered intraperitoneally into OVX or sham mice for the 6 weeks. The femur from all mice was collected 3 days after the final injection, and BMD in the femur was measured.

RESULTS

The reduction of cortical BMD and total BMD in the OVX mice was significantly ameliorated after subsequent repeated intermittent administration of (R)-ketamine, but not (S)-ketamine.

CONCLUSION

The study shows that (R)-ketamine can ameliorate the reduced cortical BMD and total BMD in OVX mice. Therefore, (R)-ketamine would be a novel therapeutic drug for women with osteoporosis.

摘要

目的

抑郁是骨质疏松症患者常见的症状。(R)-氯胺酮在啮齿类动物中比(S)-氯胺酮产生更强的效力和更持久的抗抑郁作用。在这里,我们研究了两种氯胺酮对去卵巢(OVX)小鼠(绝经后骨质疏松症的动物模型)骨密度(BMD)降低的影响。

方法

雌性 ddY 小鼠行 OVX 或假手术。随后,每周两次腹膜内给予生理盐水(10mL/kg/d)、(R)-氯胺酮(10mg/kg/d)或(S)-氯胺酮(10mg/kg/d),持续 6 周。所有小鼠的股骨在最后一次注射后 3 天收集,测量股骨的 BMD。

结果

在随后反复间歇性给予(R)-氯胺酮后,OVX 小鼠皮质 BMD 和总 BMD 的降低得到明显改善,但(S)-氯胺酮则没有。

结论

该研究表明(R)-氯胺酮可以改善 OVX 小鼠皮质 BMD 和总 BMD 的降低。因此,(R)-氯胺酮可能成为治疗骨质疏松症女性的一种新型治疗药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3961/7722686/6a31c82a8976/NPR2-40-401-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3961/7722686/93356e6aec37/NPR2-40-401-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3961/7722686/6a31c82a8976/NPR2-40-401-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3961/7722686/93356e6aec37/NPR2-40-401-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3961/7722686/6a31c82a8976/NPR2-40-401-g002.jpg

相似文献

1
Decreased bone mineral density in ovariectomized mice is ameliorated after subsequent repeated intermittent administration of (R)-ketamine, but not (S)-ketamine.去卵巢小鼠的骨密度降低,经后续重复间歇性给予(R)-氯胺酮后得到改善,但(S)-氯胺酮无效。
Neuropsychopharmacol Rep. 2020 Dec;40(4):401-406. doi: 10.1002/npr2.12132. Epub 2020 Aug 19.
2
Effects of (R)-ketamine on reduced bone mineral density in ovariectomized mice: A role of gut microbiota.(R)-氯胺酮对去卵巢小鼠骨密度降低的影响:肠道微生物群的作用。
Neuropharmacology. 2022 Aug 1;213:109139. doi: 10.1016/j.neuropharm.2022.109139. Epub 2022 May 17.
3
Short- and long-term effects of calcium and exercise on bone mineral density in ovariectomized rats.钙和运动对去卵巢大鼠骨密度的短期和长期影响
Br J Nutr. 2001 Oct;86(4):521-7. doi: 10.1079/bjn2001428.
4
Abaloparatide increases bone mineral density and bone strength in ovariectomized rabbits with glucocorticoid-induced osteopenia.阿巴洛肽可增加去卵巢合并糖皮质激素诱导骨质疏松症兔的骨密度和骨强度。
Osteoporos Int. 2019 Aug;30(8):1607-1616. doi: 10.1007/s00198-019-04999-4. Epub 2019 May 3.
5
Repeated in vivo determinations of bone mineral density during parathyroid hormone treatment in ovariectomized mice.在去卵巢小鼠甲状旁腺激素治疗期间对骨矿物质密度进行的重复体内测定。
J Endocrinol. 2001 Sep;170(3):529-37. doi: 10.1677/joe.0.1700529.
6
Intermittent minodronic acid treatment with sufficient bone resorption inhibition prevents reduction in bone mass and strength in ovariectomized rats with established osteopenia comparable with daily treatment.间歇用米诺膦酸治疗并充分抑制骨吸收可防止已发生骨质疏松的去卵巢大鼠的骨量和骨强度减少,其效果与每日治疗相当。
Bone. 2013 Jul;55(1):189-97. doi: 10.1016/j.bone.2013.02.013. Epub 2013 Feb 26.
7
Kanamycin inhibits daidzein metabolism and abilities of the metabolites to prevent bone loss in ovariectomized mice.卡那霉素抑制大豆苷元的代谢以及其代谢产物预防去卵巢小鼠骨质流失的能力。
BMC Res Notes. 2016 Jul 7;9:334. doi: 10.1186/s13104-016-2139-7.
8
Long-term zoledronic acid treatment increases bone structure and mechanical strength of long bones of ovariectomized adult rats.长期唑来膦酸治疗可增加去卵巢成年大鼠长骨的骨结构和力学强度。
Calcif Tissue Int. 2003 Apr;72(4):519-27. doi: 10.1007/s00223-002-2015-4. Epub 2003 Feb 10.
9
Effects of glucocorticoid on BMD, micro-architecture and biomechanics of cancellous and cortical bone mass in OVX rabbits.糖皮质激素对去势兔松质骨和皮质骨骨密度、微结构和生物力学的影响。
Med Eng Phys. 2012 Jan;34(1):2-8. doi: 10.1016/j.medengphy.2011.06.010. Epub 2011 Jul 19.
10
Effects of exercise training and etidronate treatment on bone mineral density and trabecular bone in ovariectomized rats.运动训练和依替膦酸治疗对去卵巢大鼠骨密度和小梁骨的影响。
Bone. 1998 Aug;23(2):147-53. doi: 10.1016/s8756-3282(98)00075-1.

引用本文的文献

1
Repurposing Ketamine in the Therapy of Depression and Depression-Related Disorders: Recent Advances and Future Potential.氯胺酮在抑郁症及相关疾病治疗中的新用途:最新进展与未来潜力
Aging Dis. 2024 Apr 29;16(2):804-840. doi: 10.14336/AD.2024.0239.
2
Sex differences in the effects of repeated ketamine infusions on bone markers in patients with unipolar and bipolar depression.单相和双相抑郁症患者重复氯胺酮输注对骨标志物影响的性别差异。
Biol Sex Differ. 2024 Jan 29;15(1):12. doi: 10.1186/s13293-024-00587-2.
3
Repeated Dosing of Ketamine in the Forced Swim Test: Are Multiple Shots Better Than One?

本文引用的文献

1
Are we repeating mistakes of the past? A review of the evidence for esketamine.我们是否在重蹈覆辙?氯胺酮相关证据的综述
Br J Psychiatry. 2021 Nov;219(5):614-617. doi: 10.1192/bjp.2020.89.
2
Molecular mechanisms of the rapid-acting and long-lasting antidepressant actions of (R)-ketamine.(R)-氯胺酮快速抗抑郁作用和长效作用的分子机制。
Biochem Pharmacol. 2020 Jul;177:113935. doi: 10.1016/j.bcp.2020.113935. Epub 2020 Mar 26.
3
Intravenous arketamine for treatment-resistant depression: open-label pilot study.静脉注射氯胺酮治疗难治性抑郁症:开放标签试点研究。
氯胺酮在强迫游泳试验中的重复给药:多次注射是否优于单次注射?
Front Psychiatry. 2021 May 11;12:659052. doi: 10.3389/fpsyt.2021.659052. eCollection 2021.
4
Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor.亚胺培南抗抑郁作用的分子机制:超越 NMDA 受体。
Mol Psychiatry. 2022 Jan;27(1):559-573. doi: 10.1038/s41380-021-01121-1. Epub 2021 May 7.
Eur Arch Psychiatry Clin Neurosci. 2021 Apr;271(3):577-582. doi: 10.1007/s00406-020-01110-5. Epub 2020 Feb 20.
4
A historical review of antidepressant effects of ketamine and its enantiomers.氯胺酮及其对映异构体的抗抑郁作用的历史回顾。
Pharmacol Biochem Behav. 2020 Mar;190:172870. doi: 10.1016/j.pbb.2020.172870. Epub 2020 Feb 5.
5
Beneficial effects of anti-RANKL antibody in depression-like phenotype, inflammatory bone markers, and bone mineral density in male susceptible mice after chronic social defeat stress.抗 RANKL 抗体对慢性社会挫败应激后雄性易感小鼠抑郁样表型、炎症性骨标志物和骨密度的有益作用。
Behav Brain Res. 2020 Feb 3;379:112397. doi: 10.1016/j.bbr.2019.112397. Epub 2019 Nov 29.
6
Molecular and cellular mechanisms underlying the antidepressant effects of ketamine enantiomers and its metabolites.氯胺酮对映异构体及其代谢物抗抑郁作用的分子和细胞机制。
Transl Psychiatry. 2019 Nov 7;9(1):280. doi: 10.1038/s41398-019-0624-1.
7
Esketamine for treatment-resistant depression: seven concerns about efficacy and FDA approval.艾氯胺酮用于难治性抑郁症:关于疗效和美国食品药品监督管理局批准的七个担忧。
Lancet Psychiatry. 2019 Dec;6(12):977-979. doi: 10.1016/S2215-0366(19)30394-3. Epub 2019 Nov 1.
8
Selective Serotonin Reuptake Inhibitor Use and Hip Fracture Risk Among Patients on Hemodialysis.选择性 5-羟色胺再摄取抑制剂的使用与血液透析患者髋部骨折风险的相关性。
Am J Kidney Dis. 2020 Mar;75(3):351-360. doi: 10.1053/j.ajkd.2019.07.015. Epub 2019 Oct 9.
9
Rapid-acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective.快速作用抗抑郁药氯胺酮及其代谢物和其他候选药物:历史概述和未来展望。
Psychiatry Clin Neurosci. 2019 Oct;73(10):613-627. doi: 10.1111/pcn.12902. Epub 2019 Jul 11.
10
Comparison of antidepressant and side effects in mice after intranasal administration of (R,S)-ketamine, (R)-ketamine, and (S)-ketamine.比较(R,S)-氯胺酮、(R)-氯胺酮和(S)-氯胺酮经鼻内给药后小鼠的抗抑郁作用和副作用。
Pharmacol Biochem Behav. 2019 Jun;181:53-59. doi: 10.1016/j.pbb.2019.04.008. Epub 2019 Apr 26.